The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram-Reference-Cited by-同舟云学术

The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram

Published:2018-02 Issue: Volume:227 Page:803-809
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Vieta Eduard,Sluth Lasse B.,Olsen Christina K.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference44 articles.

1. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder;Alvarez;Int. J. Neuropsychopharmacol.,2012

2. Diagnostic and Statistical Manual of Mental Disorders. DSM-5;American Psychiatric Association,2013

3. The safety and tolerability of vortioxetine: analysis of data from randomized placebo-controlled trials and open-label extension studies;Baldwin;J. Psychopharmacol.,2016

4. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder;Bang-Andersen;J. Med. Chem.,2011

5. A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder;Boulenger;J. Psychopharmacol.,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vortioxetine versus reuptake inhibitors in adults with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials;Asian Journal of Psychiatry;2024-11

2. Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile;European Journal of Medicinal Chemistry;2024-09

3. A cognitive neural circuit biotype of depression showing functional and behavioral improvement after transcranial magnetic stimulation in the B-SMART-fMRI trial;Nature Mental Health;2024-07-05

4. Vortioxetine for depression in adults: A systematic review and dose–response meta‐analysis of randomized controlled trials;Psychiatry and Clinical Neurosciences;2024-07-03

5. The Management of Neurocognitive Impairment in Mood Disorders;Clinical Textbook of Mood Disorders;2024-05-30